Private parties continue to actively pursue lawsuits in a range of industries, including the technology, private equity, and healthcare sectors. Recent important antitrust cases include:
In recent years, US antitrust authorities and private plaintiffs have aggressively challenged proposed mergers in a wide array of industries. Many recent notable cases have either found antitrust violations or resulted in settlements. In Ninth Inning, Inc. v DirecTV, a federal jury sided with NFL Sunday Ticket subscribers, finding the NFL liable for antitrust violations and granting plaintiffs USD4.7 billion in damages. In Burnett v National Association of Realtors, a federal jury found the National Association of Realtors and two brokerage firms liable for conspiring to inflate agent commission rates and awarded USD1.8 billion in damages. And in Chalmers et al. v NCAA, the NCAA and former Division I student-athletes settled a class action lawsuit for USD2.8 billion; the student-athletes had challenged the NCAA’s previous ban on compensation for athletes’ name, image, and likeness (NIL) rights.
Legislative developments are further elaborated in 13.1 Legislative Trends and Other Developments.
Section 4 of the Clayton Act authorises damages suits in federal court by “any person” – which includes corporations and other legal entities – “who shall be injured in his business or property by reason of anything forbidden in the antitrust laws” (15 USC Sections 7; 15[a]). The federal antitrust laws underlying private damages claims include, perhaps most prominently, Section 1 of the Sherman Antitrust Act (prohibiting concerted action that unreasonably restrains trade), and Section 2 (prohibiting single-firm conduct that maintains or creates a dominant position by unreasonably excluding competitors from a market). State antitrust laws vary, but broadly confer private rights of action on a similar basis.
The Clayton Act allows litigants to pursue damages claims that follow on from parallel scrutiny by federal law enforcement and standalone claims. Standalone claims – brought by private litigants in the absence of any governmental action against the defendants – are common in US practice. News that antitrust authorities are investigating potential anti-competitive conduct commonly prompts private litigants to quickly initiate parallel damages actions, usually while the underlying investigation remains pending.
Most federal competition matters are resolved in the US federal courts, which have exclusive jurisdiction over federal antitrust claims. An exception is the administrative adjudicatory process carried out by the Federal Trade Commission (FTC or “Commission”) (see 2.3 Impact of Competition Authorities). The Clayton Act accords plaintiffs wide latitude in choosing a venue (that is, the US federal district court in which they file suit). Venue is proper under the Clayton Act in any federal district where the defendant “resides or is found or has an agent”, or “transacts business” (15 USC Sections 15[a], 22). The parties may request, or the court may on its own decide, “for the convenience of parties and witnesses” or “in the interest of justice”, to transfer a federal antitrust litigation to a different federal district where the case “might have been brought” or to any district to which “all parties have consented” (28 USC Section 1404[a]). Different claimants may file parallel antitrust complaints in differing federal districts. When this occurs, the parties may request that the Judicial Panel on Multidistrict Litigation consolidate claims – involving “common questions of fact” – into a single federal district for co-ordinated pre-trial proceedings (28 USC Section 1407[a]).
Antitrust claims made under state law may also be heard in federal court if:
The federal antitrust enforcement agencies exercise independent judgement over which matters to litigate, but their enforcement actions are subject to judicial review in some form. The FTC, as an independent administrative agency, possesses the statutory authority to adjudicate civil claims of “unfair competition” before the agency’s own administrative law judges in trial-type proceedings. Decisions by FTC administrative judges are automatically reviewed by the FTC commissioners, and a losing defendant may appeal the Commission’s decision to the federal appellate courts.
By contrast, the U.S. Department of Justice, Antitrust Division (the “Division”), as a law enforcement agency, lacks the authority to adjudicate its own disputes, and instead must pursue enforcement actions exclusively in the federal courts. The courts likewise retain oversight of Division settlements of these cases before trial. When the Division concludes a civil antitrust investigation or litigation by settlement (known as a consent decree), the Antitrust Procedures and Penalties Act obliges the Division to file a complaint and proposed settlement materials in federal court and seek judicial approval of the settlement’s terms. However, the court’s review is limited to ensuring the settlement is in the “public interest” (15 USC Section 16).
By contrast, a criminal antitrust prosecution – which, as a matter of policy, the Division uses to target only “hardcore” per se competition offences – is overseen in its initial stages by a federal grand jury, which decides whether there is “probable cause” to believe a crime was committed, justifying the issuance of an indictment. In general, criminal antitrust defendants often plead guilty rather than stand trial. In that circumstance, the trial court has discretion to accept or reject the Division’s recommended sentence.
Consequences of Federal Antitrust Enforcement Actions
A federal antitrust enforcement action can have important consequences for parallel private litigation. For example, a final judgment or decree against a defendant in a federal antitrust enforcement action can serve as prima facie evidence against that defendant in related private litigation (15 USC Section 16[a]). In addition, the Division periodically intervenes in civil antitrust litigation to request a stay of discovery where the Division believes the exchange of evidence between the parties could undermine the Division’s ongoing criminal investigation of one or more defendants. Finally, the Division and the FTC may intervene in private antitrust litigation as an amicus curiae to offer their views on the application of the antitrust laws to a given complaint.
Section 4 of the Clayton Act requires a plaintiff to prove that the defendant(s) violated the antitrust laws and that the plaintiff has been “injured in his business or property” – that is, suffered economic loss – “by reason of” that violation (15 USC Section 15). Plaintiffs in federal antitrust cases must prove each element of their claim by a “preponderance of the evidence”, meaning they must establish through direct or circumstantial evidence that a fact is more likely than not true.
Defendants in federal antitrust litigation cannot escape liability by establishing that direct purchasers passed on to indirect purchasers some or all of an anti-competitive overcharge (Hanover Shoe v United Shoe Mach, 392 US 481 [1968]). But several state antitrust laws authorising antitrust claims by indirect purchasers provide that courts should take steps to avoid duplicative recovery, including by apportioning damages between direct and indirect purchasers, as discussed in 4.3 Direct/Indirect Purchasers.
A private litigant may pursue a claim for damages under the federal antitrust laws within four years after the cause of action has “accrued” (15 USC Section 15b). An antitrust claim accrues when the defendants’ offending conduct causes the claimant to suffer a non-speculative injury. In the case of an ongoing conspiracy, the limitations period runs from each new “overt act” in furtherance of the conspiracy that inflicts new and accumulating injury on the plaintiff (Zenith Radio Corp v Hazeltine Research, 401 US 321 [1971]). In some cases, the theory of “fraudulent concealment” may equitably “toll” (ie, pause) the limitations period where defendants have taken affirmative actions to prevent a plaintiff from learning of their cause of action.
The limitations period for private litigants can also be tolled for other statutory reasons, such as a pending government action for the same conduct (15 USC Section 16[i]). In addition, the statute of limitations for a plaintiff who opts out of a purported class action remains tolled during pendency of the class claim (American Pipe & Construction Co v Utah, 414 US 538 [1974]). In 2018, the Supreme Court clarified that this rule applies only to opt-out plaintiffs who seek to pursue damages claims on their own behalf, and not to plaintiffs who seek to re-assert class claims after a prior class has failed to achieve certification for the same issues (China Agritech v Resh, 138 S Ct 1800 [2018]).
Limitations periods under state antitrust laws vary from as few as one year to as many as six years, with four years being the most common. A small handful of states do not specify a limitations period for antitrust claims.
The duration of federal antitrust litigation varies dramatically. Most cases are dismissed or resolved before trial. Cases can be dismissed at the pleadings stage with reasonable speed, though claimants may be permitted to replead their allegations, and may appeal dismissal. Cases that survive the dismissal stage can go on for years, as the parties exchange evidence, retain experts, dispute class certification (see 4.4 Class Certification) and seek summary judgment before trial.
Class actions are at the heart of private antitrust litigation in the US. Any plaintiff suing under the federal antitrust laws may seek to pursue his or her claims on behalf of a putative class of parties whose injuries at the hands of defendants involve the same set of concerns. To maintain a class, a plaintiff must move for “class certification”, establishing by a preponderance of the evidence that the class complies with the requirements of US Federal Rule of Civil Procedure 23 (see 4.4 Class Certification).
Class litigation typically proceeds on an “opt-out” basis: members of a “certified” class are included in the resolution of the claim unless they affirmatively opt to be excluded.
The U.S. Supreme Court has ruled that “indirect purchasers” – consumers who do not purchase directly from defendants, but to whom the direct purchaser has passed on the overcharge caused by the defendants’ conspiracy – generally lack standing to pursue damages claims under the federal antitrust laws (Illinois Brick Co v Illinois, 431 US 720 [1977]). This decision is rooted in concerns for judicial economy and the challenges in apportioning damages passed from direct to indirect purchasers (and the threat that those challenges could lead to duplicative recovery).
There are exceptions to this rule, including when the direct purchaser is a party to the conspiracy. Further, since the Supreme Court announced the bar on federal indirect purchaser claims, most states have enacted what are known as Illinois Brick repealer statutes, which sanction indirect claims under state law. As a result, antitrust defendants may be forced to litigate in a single federal court against both direct purchasers under federal law and indirect purchasers under various state laws.
Although there have been calls for Congress to overturn the Illinois Brick rule, it has not done so. And the U.S. Supreme Court affirmed Illinois Brick’s bar on damages suits by indirect purchasers in 2019 – the Court’s first application of the rule to a digital market (Apple Inc v Pepper, 139 S Ct 1514 [2019]).
More generally, the U.S. Supreme Court has articulated important “limiting contours” on the right of private plaintiffs to recover damages under the antitrust laws, embodied in the requirement that plaintiffs establish the element of “antitrust standing”, which tests whether a particular plaintiff is the appropriate party to recover damages for an established antitrust violation. First, antitrust plaintiffs must demonstrate that they have suffered an “antitrust injury”, that is, an injury “of the type the antitrust laws were intended to prevent.” (Brunswick Corp v Pueblo Bowl-O-Mat, Inc, 429 US 477 [1977]). For example, a retailer that loses its distribution agreement with a manufacturer for refusing to conspire with other retailers to rig bids to sell the manufacturer’s products has not suffered antitrust injury. This is because the retailer’s harm (lost profits) does not “flow... from that which makes bid-rigging unlawful” under the antitrust laws (ie, higher prices to consumers) (Gatt Communications, Inc v PMC Associates, LLC, 711 F.3d 68 [2d Cir 2013]).
Plaintiffs must also establish they are “efficient enforcers of the antitrust laws”, an inquiry that assesses (among other things) the “directness” of the link between the asserted conduct and injury, and the existence of other “more direct” victims (Associated General Contractors of California, Inc v Cal State Council of Carpenters, 459 US 519 [1983]). These elements are not part of the government’s burden in proving an antitrust violation.
Class-certification review involves a “rigorous analysis” that “will frequently entail overlap with the merits of the plaintiff’s underlying claim” (Comcast Corp v Behrend, 569 US 27, 34 [2013]). To begin with, a plaintiff must affirmatively demonstrate that:
In addition to those “prerequisites”, a plaintiff must also establish that the putative class meets one of several enumerated bases for certification. Most antitrust class actions seek to proceed on the showing that both common questions of law or fact “predominate” over questions affecting individual members and a class action is “superior” to alternative methods of “fairly and efficiently adjudicating the controversy” (Fed R Civ P 23[b][3]).
In addition to the venue requirements of the Clayton Act (see 2.2 Courts), plaintiffs must establish that both the defendant(s) and the conduct complained of are subject to the jurisdiction of the US courts. These requirements include both personal and subject matter jurisdiction.
Personal Jurisdiction
Personal jurisdiction assesses the court’s power to hear cases against particular defendants. As a matter of constitutional due process, the federal courts can only impose liability on defendants that have sufficient “minimum contacts” with the forum state. Depending on the strength of a defendant’s forum contacts, personal jurisdiction can be general (all-purpose) or specific (conduct-linked). For corporations, in all but the most “exceptional” cases, general jurisdiction will exist only if the defendant is headquartered or incorporated in the forum (Daimler AG v Bauman, 571 US 117 [2014]).
Specific jurisdiction, which is narrower, is appropriate only for claims that “arise out of or relate to” a foreign defendant’s own purposeful contacts with the forum itself (and not just contacts with parties that reside in the forum) (Walden v Fiore, 571 US 277 [2014]). Plaintiffs must also have suffered an injury in the forum, although injury alone is not enough (Bristol-Myers Squibb v Superior Court of California, San Francisco County, 582 US 255 [2017]). The Supreme Court has recently reiterated that specific jurisdiction requires a “strong relationship among the defendant, the forum, and the litigation” (Ford Motor Company v Montana Eighth Judicial District Court, 141 S Ct 1017 [2021]).
Subject Matter Jurisdiction
By contrast, subject matter jurisdiction is the power of the court to hear a given type of claim. In the antitrust context, as courts and litigants grapple with the practical realities of increasingly global supply chains and cross-border finance, this question is frequently considered in terms of the territorial limitations applied to the Sherman Act’s bar on conspiracies that restrain trade. The US Foreign Trade Antitrust Improvements Act of 1982 (FTAIA) limits the territorial reach of US antitrust law to domestic or import commerce, and places foreign or export conduct beyond the reach of US courts unless that conduct has a “direct, substantial, and reasonably foreseeable effect” on US commerce and that effect “gives rise to” a US antitrust claim (15 USC Section 6a).
Whether the causal nexus between foreign conduct and domestic effect is sufficiently direct will depend on the facts and circumstances, including the structure of the market and the relationships of the parties. Appeals courts presently disagree on whether the FTAIA’s directness prong requires that the US effect follow as the “immediate consequence” of the foreign antitrust conduct or whether the domestic effect must only bear a “reasonably proximate causal nexus” to that conduct (Compare United States v Hui Hsiung, 778 F.3d 738 [9th Cir 2015] [“immediate consequence”], with Lotes Co v Hon Hai Precision Industries Co, 753 F.3d 395 [2d Cir 2014] [“reasonably proximate causal nexus”]). But, however the test is expressed, the appeals courts generally appear to agree that the wholly-foreign price fixing and sale of components included in goods sold to US consumers can have a direct effect on US commerce.
The exchange of evidence between parties in federal antitrust litigation is governed by the general rules for discovery in federal court. Those rules contain a permissive standard for what evidence parties may request: “any non-privileged matter that is relevant to any party’s claim or defense”, whether or not that information would ultimately be admissible at trial (Fed R Civ P 26[b][1]). Parties may request production of documents and electronically stored information, written responses to questions and requests for admissions, as well as depositions of witnesses of fact or corporate representatives. Non-US litigants may, in some circumstances, need to provide disclosure that would not be permitted under their own country’s laws. In addition, litigants may serve subpoenas seeking discovery from non-litigants.
Under these standards, discovery in US federal litigation is, in general, more burdensome, expensive, and time-consuming than in many other jurisdictions. In the antitrust context, discovery can be particularly costly because class actions and other antitrust cases usually raise a variety of complex issues. Some constraints on the scope of discovery do exist. Since 2015, the federal rules have limited permissible discovery to relevant information that is “proportional to the needs of the case” (Fed R Civ P 26[b][1]). Parties may resist discovery requests on a variety of grounds, including that the requested materials fail the relevance standard or that compliance would be unduly burdensome under the circumstances.
In addition, the Supreme Court – recognising that the burdens of antitrust discovery can push defendants to settle even weak cases – has instructed lower courts to take seriously their gatekeeping function at the motion to dismiss stage. In 2007, the Supreme Court clarified that to survive a motion to dismiss an antitrust claim on the pleadings, plaintiffs must allege specific facts, which if accepted as true, plausibly suggest, and are not merely consistent with, an antitrust violation” (Bell Atlantic Corp v Twombly, 550 US 544 [2007]). This decision has raised the bar on what plaintiffs must allege, often before a court will allow plaintiffs to request discovery from defendants.
The attorney-client privilege protects from the discovery process confidential communications between an attorney and client made for the primary purpose of seeking or providing legal advice. In the corporate setting, the attorney-client privilege extends to communications between attorneys and those employees who “will possess the information needed by the corporation’s lawyers” in order to provide sound legal advice, as well as to those employees who “will put into effect” that advice (Upjohn Co v United States, 449 US 383 [1981]). Importantly, in-house counsel communications may be protected by attorney-client privilege under US law. Furthermore, the privilege protects attorney-client communications made with a business purpose, so long as at least “one of the significant purposes” of the communication was obtaining or providing legal advice (see Kellogg Brown & Root, Inc, 756 F.3d 754 [DC Cir 2014]).
Internal corporate communications that do not include attorneys may sometimes remain subject to the privilege, including where those communications reflect an attorney’s legal advice or where a non-attorney – such as in a compliance or internal audit role – is gathering facts at the direction of an attorney for the purpose of facilitating the attorney’s provision of legal advice to the company.
Limitations (and Exceptions to Those Limitations) to the Scope of Privilege
There are some important limitations on the scope of the privilege protection. For example, only the substance of legal advice (or of a request for advice) is protected. The fact of an attorney-client communication is not protected. Nor are pre-existing non-privileged materials protected simply because they are shared between an attorney and a client. In addition, a party generally waives privilege protection by failing to maintain the confidentiality of legal advice, including by sharing that advice with third parties. There is no exception to this waiver for voluntary disclosure of privileged communications to the government (though, importantly, the US antitrust authorities do not demand that an investigative target hand over privileged materials to be seen as co-operative in a government investigation). And the privilege does not protect attorney-client communications made for the purpose of committing or furthering a crime or fraud (United States v Zolin, 491 US 554 [1989]).
The “common interest” protection – an exception to the rule that sharing legal advice with third parties results in a privilege waiver – safeguards against the compelled disclosure of communications between parties and their respective counsel when aligned in a common legal interest. There is some disagreement among the federal appeals courts as to whether the common interest protection is limited to communications between parties when threatened by litigation; a number of appeals courts recognise it applies to the “full range of communications otherwise protected by the attorney-client privilege” without regard to whether litigation is threatened (United States v BDO Seidman, LLP, 492 F.3d 806 [7th Cir 2007] [agreeing with at least five sister circuits that the threat of litigation is not required for the common interest protection to apply]; but see Santa Fe Int’l Corp, 272 F.3d 705 [5th Cir 2001] [finding that the protection only applies where there is the threat of litigation]). In federal antitrust litigation, co-defendants regularly invoke the common interest protection to share materials and collaborate on defence strategy. Frequently, co-defendants will sign a joint defence agreement formalising that arrangement (but this step is not strictly required for the common interest protection to apply).
A related protection arises under the “work-product” doctrine, which shields from disclosure materials “prepared in anticipation of litigation” (Fed R Civ P 26[b][3]). It protects both “documents and tangible things” and the “mental impressions, conclusions, opinions, or legal theories of a party’s attorney”. The work product doctrine is not an absolute bar to compulsory disclosure of qualifying materials. Rather, an adversary may ask the court to compel disclosure of work product by showing that the requesting party has a “substantial need” for the materials in order to prepare its case and that the party cannot, without “undue hardship”, obtain through “other means” the “substantial equivalent” of the requested materials (Fed R Civ P 26[b][3][A]). In practical terms, however, this is a very challenging standard to meet.
As described in 2.3 Impact of Competition Authorities, agreements to settle most forms of enforcement proceedings by the US federal antitrust authorities are typically made public in the course of a federal court’s review of the proposed resolution. One exception to this general rule is for parties who qualify for leniency pursuant to the Department of Justice, Antitrust Division’s Corporate Leniency Policy. The Leniency Program, a centerpiece of the Division’s criminal cartel enforcement efforts for more than 25 years, accords immunity from criminal antitrust prosecution to corporations that report their role in a per se antitrust violation at an early stage and meet certain other conditions, including co-operating fully with the Division’s prosecutions of co-conspirators and making restitution to injured parties.
To encourage applicants to come forward, Division policy is to treat as confidential the identity of leniency applicants and the materials they provide. The Division acknowledges it will disclose the identity of a leniency applicant if ordered to do so by a court. But such an order would be unusual. While at least one appeals court has held that the Division must disclose leniency agreements pursuant to requests under the US Freedom for Information Act (FOIA), that court also recognised that details within those materials identifying a leniency recipient could be exempt from FOIA disclosure (Stolt-Nielsen Transportation Group Ltd v United States, 534 F.3d 728 [DC Cir 2008]).
That said, a conditional leniency recipient will likely identify itself to plaintiffs in follow-on civil litigation, in an effort to fulfil its restitution obligation under the Leniency Policy by co-operating with plaintiffs and earning the resulting de-trebling of damages available under the Antitrust Criminal Penalty Enhancement and Reform Act of 2004 (ACPERA).
In addition, public companies may face other legal obligations, such as under the securities laws, to disclose their status as the recipient of leniency.
On 4 April 2022, the Division updated its Leniency Policy. This update imposed a number of more stringent obligations on leniency applicants while giving the Department of Justice more discretion as to when to award leniency. These additional obligations include:
Litigants in US federal court may rely on, and compel, testimony from fact witnesses both before and during trial. Prior to trial, the principal tool for compelling a witness to testify is a deposition, in which the requesting litigant compels the witness to attend an in-person interview to provide sworn testimony in front of a judicial officer. Parties can also request that opposing parties respond to written questions, called interrogatories. In either case, the court may compel the witness to respond under threat of sanction. During trial, judges generally prefer live testimony so that the factfinder can evaluate the witness’s credibility and so that the opposing party can cross-examine the witness. Deposition testimony may be admitted into evidence to contradict or impeach testimony given during trial, or in some cases, if a witness is unavailable to testify in court.
The rules governing federal court litigation, including antitrust claims, permit parties to rely on expert evidence both before and during trial. In the antitrust context, the parties nearly always rely on one or more experts to establish or challenge key issues, including:
Experts will generally prepare a written report (which must be provided to the opposing party prior to trial) and provide in-person testimony (Fed R Civ P 26[a][2]).
An expert’s testimony is admissible as evidence only if the court determines that:
This assessment requires the court to scrutinise the expert’s particular methods and their degree of acceptance in the relevant field (see Daubert v Merrell Dow Pharmaceuticals, Inc, 509 US 579 [1993]; Fed R Evid 702). Before or during trial, parties can challenge the admissibility of opposing expert testimony or dispute the validity of that testimony. Parties may depose opposing experts, cross-examine them at trial, and seek to introduce evidence that purports to conflict with an expert’s conclusions.
The Clayton Act does not provide for punitive damages. Instead, plaintiffs who suffer antitrust injury may recover treble damages. For consumer plaintiffs injured by a price-fixing or a market-division cartel, common measures of damages include the amount of the overcharge caused by the conspiracy, measured by identifying the price they would have paid but for the restraint. For competitor plaintiffs injured by a monopolist’s exclusionary conduct, a common measure of damages is the plaintiff’s resulting lost profits.
As with the other elements of a civil antitrust action, plaintiffs must establish the value of their injury by a preponderance of the evidence standard. The Clayton Act permits damages assessments to be made “in the aggregate” according to “statistical or sampling methods” accepted by the court (15 USC Section 15d). In practice, antitrust plaintiffs nearly always rely on an expert to quantify damages according to an accepted model. Plaintiffs must also prove that the damages were not caused by separate and independent factors (ie, they are required to disaggregate the losses caused by the alleged antitrust violation).
As discussed in 2.5 Pass-On Defence, defendants in federal antitrust litigation cannot escape liability by establishing that direct purchasers passed on to indirect purchasers some or all of an anti-competitive overcharge (Hanover Shoe v United Shoe Mach, 392 US 481 [1968]).
A statutory exception to the treble damages rule exists for defendants who successfully receive leniency from prosecution under the Division’s Leniency Policy. Under ACPERA, leniency recipients who provide “satisfactory co-operation” to plaintiffs in follow-on civil litigation may have their damages limited to actual damages, rather than treble damages. Courts have not assessed with any precision what constitutes a defendant’s satisfactory co-operation, but defendants can expect that to receive what is known as ACPERA credit they will need to provide evidence to plaintiffs in support of their antitrust claims.
Section 4 of the Clayton Act enables plaintiffs to recover interest on damages awards. Pre-judgment interest awards are discretionary: a federal district court may award interest on actual damages – but not for the full treble damages available under the antitrust laws – for any period from the date of service of the plaintiff’s pleading to the date of judgment, when just in the circumstances. That standard considers whether defendants acted intentionally to delay resolution of the proceedings (15 USC Section 15[a]).
By contrast, post-judgment interest is mandatory: the court must award interest on a damages award until defendant(s) transfer the funds to the plaintiff(s). The interest – at a rate equal to the weekly average one-year constant maturity Treasury yield for the calendar week preceding the date of the judgment – is calculated from the date of the entry of judgment and is compounded annually (28 USC Section 1961). Each state’s antitrust laws provide for post-judgment interest; the law on pre-judgment interest varies from state to state.
US antitrust law follows the common law tort principle of joint and several liability, which means each defendant can be responsible for paying the entire damage award for the conspiracy as a whole (not just for damages to purchasers with whom a given defendant transacted).
But, as discussed in 6.3 Leniency and Settlement Agreements and 8.1 Damages: Assessment, Passing on and Interest, successful recipients of leniency from Division antitrust prosecution who provide “satisfactory co-operation” to follow-on litigants may have their civil damages claim limited to actual damages under ACPERA. In addition, the leniency recipient will not be liable to plaintiffs on a joint-and-several basis for the harm from the entire conspiracy but will, instead, be held liable only for its own harm to the plaintiffs.
The U.S. Supreme Court has ruled that a defendant found jointly and severally liable under the federal antitrust laws for treble damages, costs, and attorneys’ fees has no right to seek contribution from co-conspirators for their share of the damages award (Texas Industries Inc v Radcliffe Materials, Inc, 451 US 630 [1981]). Rather, a single defendant may have to pay the entire damages award for three times the harm caused by the entire conspiracy. A court may subtract from the damages calculation any settlement other defendants have paid to resolve the litigation, but those settlement amounts are likely to reflect a discount to the settling defendants.
This dynamic can create pressure on defendants to settle before trial by exposing non-settling defendants to the risk of bearing a disproportionate share of liability for their role in a multi-party conspiracy. Courts do not permit co-defendants to agree to indemnify each other for liability but have generally upheld agreements between them to pay a proportionate share of any judgment based on, eg, each defendant’s market share.
The Clayton Act permits private plaintiffs to sue for injunctive relief against any “threatened loss or damage by a violation of the antitrust laws.” (15 USC Section 26.) To obtain injunctive relief, a plaintiff must show that:
The Clayton Act also allows plaintiffs to seek interim relief – in the form of a preliminary injunction that can be obtained prior to trial – if the plaintiff is able to show a “likelihood of success on the merits” of its claim and meet other requirements (North American Soccer League, LLC v US Soccer Fed’n, Inc, 883 F.3d 32 [2d Cir 2018]). A preliminary injunction requires a hearing and notice to the opposing party (although in exceptional circumstances parties can seek a temporary restraining order without such notice or a hearing) (Fed R Civ P 65). The party seeking a preliminary injunction must post a security bond to compensate the opposing party if the injunction is found to have been unwarranted. Notably, the bar on damages claims by indirect purchasers under the federal antitrust laws does not extend to claims for injunctive relief.
Alternative dispute resolution is available in antitrust litigation on similar bases as it is in other federal court litigation. Federal judicial policy favours arbitration, as a matter of contract between parties. While courts cannot compel parties to arbitrate their disputes in the absence of an agreement between them to do so, courts will rigorously enforce arbitration agreements according to their terms. In recent years, the U.S. Supreme Court has applied this principle to arbitration agreements in boilerplate consumer contracts, in ways that have important consequences for private antitrust litigants. The Court has held that parties may not be compelled to arbitrate on a class-wide basis, in the absence of an agreement to do so (Stolt-Nielsen SA v AnimalFeeds Int’l Corp, 559 US 662 [2010]). A year later, the Court invalidated state laws seeking to bar enforcement of class arbitration waivers in consumer agreements (AT&T Mobility LLC v Concepcion, 563 US 333 [2011]).
These rulings could make it more challenging for consumers to pursue class-wide recovery under the antitrust laws. Indeed, most recently, the Supreme Court affirmed – in the antitrust context – that contractual waiver of class arbitration is enforceable even if the cost of individually arbitrating exceeds a claimant’s potential for recovery (American Express Co v Italian Colors Restaurant, 570 US 228 [2013]).
Litigation funding is a developing industry in the USA and may be available to support civil litigation under the antitrust laws. But opponents of litigation funding have challenged these arrangements as being illegal “champerty”, the practice of acquiring an interest in pursuing a third party’s cause of action, in exchange for a portion of the proceeds if litigation succeeds. See, eg, Boling v Prospect Funding Holdings LLC, 771 Fed. Appx. 562 (6th Cir. 2019).
In the past year, litigation funding numbers dipped in the USA, with some funders winding down and exiting the market. Commercial litigation funders committed about 14% less capital to new deals in 2023, according to public reports that note funders were hampered by broader financial market trends that prompted institutional investors to allocate money elsewhere. In 2023, US litigation finance companies committed USD2.7 billion to new financing, down from USD3.2 billion in 2022.
Section 4 of the Clayton Act provides that plaintiffs “shall recover” the costs associated with successfully litigating their claim, including “a reasonable attorney’s fee” (15 USC Section 15[a]). Typically, plaintiff lawyers acting for a purported class work on contingency and seek to recover a percentage of any court-approved settlement or trial award. By contrast, defendants have no general statutory right to recover their costs of successfully defending a federal antitrust litigation. The lone means of recovering defence costs is for the court to impose monetary sanctions on plaintiffs under the federal rules, for example, based on a finding that plaintiffs (or their attorneys) have asserted frivolous claims or arguments (Fed R Civ P 11).
Sanctions – particularly significant monetary penalties – are exceedingly rare, and an unreliable source of recovery of defence costs. The unavailability of defence costs to serve as a headwind on speculative antitrust claims is one reason the courts take seriously their gatekeeper role in assessing defendants’ threshold challenges to the sufficiency of an antitrust complaint.
Typically, courts will not order a litigant to post security for its opponent’s litigation costs. The exception is that parties seeking preliminary injunctive relief must provide a security in an amount sufficient to pay the costs and damages sustained if the party is found to have been wrongfully enjoined or restrained (Fed R Civ P 65).
A litigant adversely affected by a decision of a federal district court may seek to appeal that decision to an intermediate federal court of appeals. Parties may generally appeal a lower court’s conclusions of law according to a de novo standard, under which the appeals court will analyse the legal question without deferring to the district court’s analysis. While an appellant may also challenge a lower court’s factual findings, the appeals court will apply a far more deferential standard of review, generally leaving fact conclusions undisturbed unless clearly erroneous.
Whether, and when, a party may challenge a district court decision can take on great significance, particularly in complex litigation such as an antitrust class action. A party generally has the right to appeal “final decisions of the district courts” (28 USC Section 1291). A decision is “final” if it “ends the litigation on the merits” (Catlin v United States, 324 US 229 [1945]). The policy of the “final judgment rule” is intended to promote efficiency and limit delay, by seeking to ensure that, where possible, all challenges to lower court decisions are resolved in a single appeal.
By contrast, only in limited circumstances will courts permit appeals of interlocutory orders that do not finally resolve the dispute. In general, interlocutory appeals are reserved for “controlling questions of law” about which there is “substantial ground for difference of opinion” and resolution of which would “materially advance the ultimate termination of the litigation” (28 USC Section 1292[b]). The federal rules authorise – but do not require – interlocutory appeal of a decision on class certification (Fed R Civ P 23[f]). Parties who lose on appeal may petition the U.S. Supreme Court for final review of the appellate decision. Supreme Court review is discretionary, and as a practical matter, is rarely granted.
Pennsylvania Antitrust Bill Passes the House
On 2 July 2024, the Pennsylvania Open Markets Act (the “Act”) passed the Pennsylvania House by a bipartisan vote of 112-89 and is now headed to the state Senate. Pennsylvania is the only state without a state antitrust law. The proposed Act is designed to protect consumers, local business owners, and workers by prohibiting anticompetitive behaviour and keeping markets open and fair. In addition, this proposed bill would increase penalties for antitrust violations and give the Attorney General new powers to investigate companies that attempt to monopolise any part of the economy. The Act would authorise the Attorney General to issue subpoenas and bring civil actions to seek injunctive relief, civil penalties, divestitures, restitution, and disgorgement. In addition, the Act would allow the Attorney General to seek criminal penalties for antitrust violations of up to one million dollars and up to four years in prison.
Federal District Courts in Texas and Pennsylvania Create Potential Circuit Split on Enforceability of FTC’s Non-Compete Ban for Parties
In Ryan LLC v Federal Trade Commission, Judge Ada Brown of the US District Court for the Northern District of Texas issued a preliminarily injunction enjoining a new FTC rule that, with limited exceptions, would prohibit employers from entering into non-compete agreements with employees. In her decision, Judge Brown held that “the FTC lacks substantive rulemaking authority with respect to unfair methods of competition” and “has exceeded its statutory authority in promulgating the Non-Compete Rule.” She also found that the FTC based the rule “on inconsistent and flawed empirical evidence” and failed “to consider the positive benefits of non-compete agreements.” Although Judge Brown initially declined to issue a nationwide stay, she intends to rule on the full merits of the case by 30 August 2024.
Conversely, in ATS Tree Services v Federal Trade Commission, Judge Kelley B. Hodge from the Eastern District of Pennsylvania denied a preliminary injunction that would have stayed enforcement of the non-compete rule. Judge Hodge denied the preliminary injunction because she found that the FTC had the authority to issue the rule, ATS Tree Services had not shown that enforcement of the rule would cause irreparable harm, and ATS Tree Services was not likely to succeed on the merits. This decision conflicts with the Ryan court in Texas, setting up a potential circuit split.
In the absence of court intervention, the FTC’s non-compete rule will take effect on 4 September 2024.
Algorithmic Pricing
Legislators have recently expressed their concern over potential misuse of artificial intelligence and algorithmic pricing. To address these concerns, in February 2024, Senator Amy Klobuchar, Chairwoman of the Senate Judiciary Subcommittee on Competition Policy, Antitrust, and Consumer Rights, along with Senators Ron Wyden (D-OR), Dick Durbin (D-IL), Peter Welch (D-VT), Mazie Hirono (D-HI), and Richard Blumenthal (D-CT), introduced the Preventing Algorithmic Collusion Act to prevent companies from using algorithms to collude to set higher prices.
Additionally, US agencies are focused on the potential for algorithmic pricing to lead to price fixing and have withdrawn long-established safety zones that provided guidance on when competitors could share pricing and salary information. Ongoing cases concerning algorithmic collusion include DOJ’s intervention concerning litigation against RealPage, which allegedly co-ordinated higher prices among lessors of accommodations by collecting their competitively sensitive information and feeding it into an algorithm, and recommending prices based on the output. The DOJ has also alleged that Agri Stats, a data company in the meat processing industry, operated an information-sharing scheme that allowed competitors to exchange vast quantities of competitively important data.
Growth in Antitrust Class Actions
The USA continues to represent the most mature and developed market for antitrust class actions. In 2024-2025, the spotlight on antitrust class actions is expected to continue, particularly focusing on Big Tech. Landmark DOJ and FTC actions against Google, Apple, and Meta are set to test the limits of antitrust laws in the digital realm. Aggressive government enforcement is helping to fuel continued private class actions addressing similar issues.
2001 K Street
NW
Washington DC
20006
USA
+1 202 912 5000
+1 202 912 6000
leigh.oliver@cliffordchance.com www.cliffordchance.com/home.htmlLeading Technology Cases
Ongoing and recent lawsuits against Meta, Google, Apple, and other technology companies show that the Federal Trade Commission (FTC), the Department of Justice (DOJ) Antitrust Division, and state attorneys general are continuing their scrutiny of the technology sector.
Meta
In December 2020, the FTC and a group of state attorneys general filed parallel suits against Meta (then Facebook) in federal district court in the District of Columbia. The complaints accused Meta of monopolising the personal social media networking market through its acquisitions of Instagram and WhatsApp. Judge James Boasberg ruled that the states’ case was barred by the doctrine of laches, which prevents a case from moving forward when an unreasonable delay in filing suit harms a defendant. After the FTC amended its complaint, Judge Boasberg ruled that the FTC had alleged a plausible claim against Meta. As of July 2024, summary judgment motions are pending, and a trial date has not been set.
In 2020, the DOJ sued Google, alleging that it abused its market power in search engines to suppress competition from rivals, thus hampering innovation. Closing arguments concluded in May 2024, and the parties are awaiting a decision on liability from US District Judge Amit Mehta in the District of Columbia. Another trial against Google is set to commence in September 2024 in a case involving advertising technology in the Eastern District of Virginia. In that case, US District Judge Leonie Brinkema denied Google’s motion for summary judgment, allowing the DOJ, joined by eight states, to pursue their claim that Google monopolised the technology that powers online advertising through anticompetitive conduct in acquiring rivals, like AdMeld, and forcing advertisers and publishers to use the company’s products.
Apple
In March 2024, following years of investigation, the DOJ, fifteen states, and the District of Columbia sued Apple in federal district court in New Jersey. Their complaint accuses Apple of:
Live Entertainment and Ticket Industry Updates
In May 2024, the DOJ sued Live Nation Entertainment Inc. and its subsidiary, Ticketmaster LLC. The DOJ alleged that Live Nation carried out monopolistic and anti-competitive conduct in the live concert industry. The DOJ’s lawsuit could have far-reaching implications, such as revamping the current structure and operations of the live entertainment sector. For example, smaller promoters and artists may gain more bargaining power for terms and conditions when booking live entertainment venues.
DOJ’s complaint centres around a series of strategies that Live Nation allegedly employed to stifle competition and maintain a dominant market position. One of the key accusations against Live Nation is that it issued retaliatory threats against concert venues that considered using competing ticket providers to coerce venues into exclusionary contractual agreements. By limiting the ticket provider options to both venues and consumers, Ticketmaster allegedly preserves its control over the ticketing service industry.
Another significant aspect of the DOJ’s case is the allegation that Live Nation has strategically acquired regional concert promoters to eliminate competition. According to the complaint, these acquisitions reduce opportunities for new and existing competitors to challenge Live Nation’s position and allegedly solidified the company’s market dominance.
The lawsuit represents a direct attack on Live Nation’s business practices and its business model. If the DOJ is successful, the consequences for Live Nation could be substantial, potentially leading to a restructuring of its operations and the imposition of behavioural remedies designed to restore competition within the industry. The complaint does not identify specific behavioural remedies, but in similar cases, remedies have included prohibiting exclusionary contracts or retaliation tactics.
The Latest in Sports Litigation
The National Football League (NFL) and National Collegiate Athletic Association (NCAA), two of the United States’ major sports entities, are currently facing antitrust legal challenges.
A group of NFL Sunday Ticket subscribers, along with a coalition of bars and restaurants, launched a lawsuit against the NFL, targeting its exclusive broadcasting arrangement with DirecTV for the NFL Sunday Ticket package. The NFL Sunday Ticket package described in the complaint allows subscribers to watch any NFL game regardless of the local market. Originally filed in 2015, the case was dismissed in 2017 only to be restored by the Ninth Circuit Court of Appeals two years later. In February 2023, Central District of California Judge Philip Gutierrez certified the case to proceed as a class action. After a three-week trial in June 2024, a federal jury in California found for the plaintiffs and awarded them a total of USD4.7 billion. But in August 2024, Judge Gutierrez granted the NFL’s motion to vacate the jury award, finding the jury’s calculation to be based on “guesswork or speculation.” Judge Gutierrez added that “[t]he jury did not follow the Court’s instructions and instead relied on inputs not tied to the record to create its own ‘overcharge.’” Judge Gutierrez also entered judgment for the NFL on all remaining plaintiff claims. The subscribers are appealing these decisions to the Ninth Circuit.
The NCAA, the leading organisation for regulating student athletics at American universities, is in the spotlight regarding the control of athletes’ name, image, and likeness (NIL) rights. On 23 May 2024, the NCAA announced a USD2.8 billion settlement in a class action lawsuit brought by former Division I student-athletes. The lawsuit challenged the NCAA’s previous ban on NIL compensation, which prevented athletes from profiting from their own personal brand while in college. Although the settlement marks a significant step forward, the NCAA continues to face legal scrutiny over its policies on NIL rights, athlete compensation, and the rules governing athlete transfers. For example, 16 ex-college basketball players, victors of the 2008 national basketball championship, have initiated a class action lawsuit against the NCAA for compensation from NIL rights, as the 2008 team’s highlights are still broadcast each year during the annual March Madness tournament. (Chalmers et al. v. NCAA et al.)
While the settlement resolves one dispute over NIL rights, it has major issues on its face and has been criticised for, among other things, primarily benefiting the plaintiff attorneys while providing little to no benefit for most athletes. Indeed, after being divided amongst the numerous claimants, the settlement may result in minimal financial gain for each individual athlete, with the overwhelming majority going to football and basketball players from the Power 5 conferences. The settlement also does not resolve the issue of whether athletes can be treated as employees, and institutes roster caps in place of scholarship limits (potentially limiting the ability for walk-on athletes to participate in collegiate sports at all). Finally, as the settlement terms must still be approved by a judge, the landscape for NIL compensation remains hazy at best and will continue to be an ongoing issue.
Increased Scrutiny of the Private Equity Industry
The private equity industry is facing increased antitrust scrutiny. In November 2023, the FTC filed suit against U.S. Anesthesia Partners, Inc. (USAP) and Welsh, Carson, Anderson & Stowe, a private equity firm. The FTC alleged that USAP and Welsh Carson engaged in an anticompetitive scheme, through serial acquisitions, to drive up the price of services by consolidating anesthesiology practices in Texas. In May 2024, Welsh Carson successfully moved to be dismissed from the suit; however, the federal district court denied USAP’s motion to dismiss because the court determined that the FTC had sufficiently alleged a case against USAP. In May 2024, the FTC and the DOJ announced a joint request for members of the public to provide the agencies with information that can be used to identify serial acquisitions that have led to consolidation that has harmed competition. The public comment period is scheduled to end on 20 September 2024.
Information Sharing and Algorithmic Collusion
The DOJ and the FTC are increasingly investigating possible “algorithmic collusion”, where competitors are alleged to use sophisticated algorithms to exchange non-public sensitive information, ultimately co-ordinating to fix prices. In August 2023, manufactured homeowners filed a class action lawsuit in Illinois federal district court against Datacomp Appraisal Systems, Inc., the nation’s largest provider of manufactured and mobile home data, as well as against several other companies that own or have controlling interests in more than 150 housing communities across the country (Hajek v Datacomp Appraisal Systems, Inc.). A total of eight cases against Datacomp have been consolidated under the Hajek case. The complaint alleges that the defendants conspired to fix, raise, and maintain lot rental prices for manufactured and modular homes, resulting in manufactured home residents paying elevated rents. Defendants Datacomp and Murex Properties, LLC have filed motions to dismiss, which are pending. In April 2024, a federal district judge granted defendants’ motion to stay discovery pending a ruling on the motions to dismiss.
In November 2023, the DOJ submitted a statement of interest and memorandum of law in In Re: RealPage, Rental Software Antitrust Litigation (No. II). This case involves two complaints. One alleges that RealPage and fourteen defendant landlords unlawfully agreed to use RealPage software recommendations to raise multifamily rental housing prices. RealPage is a technology platform that provides property management software for real estate owners and managers. The complaint alleges that RealPage unlawfully combines competing landlords’ decision-making on housing prices and that RealPage uses competitively sensitive data provided by landlords to generate pricing and supply recommendations. RealPage allegedly then pressures landlords to implement RealPage’s prices, which results in landlords adopting RealPage’s recommendations 80-90% of the time. The second complaint alleges a similar scheme to inflate the prices of student housing. The DOJ opposed the motions to dismiss these complaints, arguing that the antitrust laws apply to algorithm-based pricing schemes and that price-fixing is illegal even when entities use algorithms. In March 2024, the FTC and DOJ jointly filed a statement of interest in a private case, Cornish-Adebiyi v Caesars Entertainment, Inc. In this statement, the agencies argue that hotels may not use an algorithm to collude on room pricing by engaging in practices that would be illegal if done by a person. The statement seeks to clarify the legal framework applicable to accusations of per se illegal price fixing in the context of competitors employing a shared algorithm. The statement further emphasised that per se illegal price fixing (i) does not require direct communications among conspirators and (ii) can involve agreements around non-binding pricing recommendations.
Latest Real Estate Cases
In November 2023, a federal jury in Burnett v National Association of Realtors found the National Association of Realtors (NAR) and two brokerage firms liable for conspiring to inflate agent commission rates and awarded USD1.8 billion in damages. The suit alleged that NAR rules required home sellers to pay commissions to the broker or agent representing the buyer. It also alleged that defendants enforced these rules through anticompetitive and unlawful practices in violation of federal antitrust law. The NAR and both firms settled, choosing not to appeal. The NAR agreed to pay USD418 million in damages and to do away with rules on commissions. Brokerage HomeServices of America declined to join the settlement, but later agreed to pay USD250 million in damages to settle the case.
2023 Merger Guidelines and Their Implications
In December 2023, the DOJ and FTC released the final version of their 2023 Merger Guidelines, which set out 11 guidelines for merger enforcement. The recent cases discussed below illustrate how the agencies are using some of these new guidelines to challenge proposed transactions.
IQVIA‒Propel Media: Guideline 1 (lowers market share thresholds for finding that a merger of competitors is likely to harm competition) and Guideline 5 (evaluates whether a transaction may foreclose competition by limiting a rival’s access to an input that is used to compete)
In July 2023, the FTC sued to block IQVIA’s acquisition of Propel Media under theories from Guidelines 1 and 5. The FTC sought a preliminary injunction alleging that the acquisition would (i) eliminate horizontal competition between the parties in the sale of digital advertisements to healthcare providers and (ii) enable IQVIA to withhold key healthcare data from Propel’s rivals, limiting their ability to compete with the merged firm. A federal judge granted the FTC’s preliminary injunction on the horizontal theory of harm, without reaching the vertical theory, and the parties abandoned the transaction in January 2024.
Sanofi‒Maze Therapeutics: Guideline 2 (evaluates whether mergers eliminate substantial competition between firms)
In December 2023, the FTC sued to block Sanofi’s worldwide exclusive licensing deal with Maze related to Maze’s glycogen synthase 1 products, including its lead clinical candidate MZE001. The FTC alleged that (i) Sanofi was a monopolist and had been able to raise prices for its existing Pompe disease products without losing business; (ii) Sanofi recognised the threat from Maze’s positive clinical trial results; (iii) Maze’s product was easier to administer (twice-daily oral) versus Sanofi’s IV therapy; and (iv) other competitors were in Phase 1 and Sanofi viewed Maze as the leading threat. Following the FTC’s move to block the deal, Sanofi terminated the proposed acquisition that same month.
Amgen‒Horizon Therapeutics: Guideline 6 (examines whether mergers might entrench or expand an already dominant market position)
In May 2023, the FTC sued to block Amgen, a leading biopharmaceutical company, from acquiring Horizon Therapeutics. Horizon manufactures the only FDA-approved treatment for thyroid eye disease and the only FDA-approved treatment for chronic refractory gout. The FTC alleged that (i) the transaction would allow Amgen to “sustain and entrench” Horizon’s monopoly position through cross-market bundling practices which Horizon on its own could not engage in, and (ii) the cross-market bundling practices would deter Horizon’s competitors from coming to market because they could not compete with Amgen’s bundles.
The parties entered a settlement before going to trial, and the transaction closed in October 2023. The settlement prohibits Amgen from bundling an Amgen product with either Horizon treatment. In addition, Amgen may not condition any product rebate or contract term related to an Amgen product on the sale or positioning of either one of these drugs. Amgen is also barred from using any product rebate or contract term to exclude or disadvantage any product that would compete with the two treatments.
Aggressive Merger Challenges
Microsoft/Activision
Both the DOJ and the FTC have been aggressive in challenging proposed mergers that they believe run afoul of the antitrust laws, although their challenges have sometimes been unsuccessful. In January 2022, Microsoft announced it would acquire Activision Blizzard, a game development company, for USD68.7 billion. The transaction promised to make Microsoft the third largest gaming company in the world. In July 2023, Microsoft prevailed in opposing the FTC’s request for a preliminary injunction in the Northern District of California, allowing Microsoft to close the deal in October 2023. The FTC has appealed the district court’s decision to the Ninth Circuit, and a decision is pending.
In addition, a group of gamers filed a private lawsuit, Demartini et al v Microsoft Corp., in December 2022, followed by an amended complaint in April 2023. In April 2024, the private plaintiffs failed to obtain a preliminary injunction and a temporary restraining order to block Microsoft from further integrating Activision Blizzard into its business. The case remains ongoing and is currently in discovery with depositions underway.
Intercontinental Exchange/Black Knight
In March 2023, the FTC sued to block the proposed USD13.1 billion merger of Intercontinental Exchange, Inc. (ICE) with its top competitor, Black Knight, Inc. ICE is the nation’s largest provider of home mortgage loan origination systems and other key lender software tools. The FTC alleged that the deal would drive up costs, reduce innovation, and reduce lenders’ choices for tools necessary to generate and service mortgages.
In August 2023, the FTC approved a proposed consent order to resolve its antitrust concerns about the transaction. The settlement required Black Knight to divest its Empower and Optimal Blue businesses, which provide services in the mortgage origination process. Black Knight also agreed to provide relief designed to promote the success of the divested businesses.
Novant Health/Community Health Systems (CHS)
In January 2024, the FTC sued to block Novant Health, Inc.’s proposed USD320 million acquisition of two North Carolina hospitals from CHS, alleging that Novant’s acquisition of Lake Norman Regional Medical Center and Davis Regional Medical Center from CHS would raise prices and reduce incentives to invest in quality and innovative care that would benefit patients.
In June 2024, a federal judge in the Western District of North Carolina denied the FTC’s request for a preliminary injunction. The judge’s order looked beyond market share figures, considering the broader commercial context, to assess the impact on competition. The court ruled against the FTC because it found that the deal was not likely to lead to anticompetitive behaviour and that the public equities weighed in favour of allowing the sale to go forward.
But Novant’s victory was short lived. On 18 June 2024, the U.S. Court of Appeals for the Fourth Circuit enjoined the transaction pending the FTC’s appeal. Later that same day, Novant announced that it had decided to terminate the acquisition because of the “FTC’s continued roadblocks”.
Other Notable Merger Litigations
In January 2024, the U.S. District Court for the District of Massachusetts blocked JetBlue Airways Corp.’s proposed USD3.8 billion acquisition of Spirit Airlines, agreeing with the Department of Justice that the merger would hurt low-cost airline consumers and cause anticompetitive effects, because the two airlines currently compete head-to-head on multiple routes.
In April 2024, the FTC moved to prevent the merger between Tapestry, Inc. and Capri Holdings Ltd., valued at USD8.5 billion. The FTC’s main argument is that the merger would reduce competition in the affordable luxury handbag market, including between Capri’s brand Michael Kors and Tapestry’s brands Coach and Kate Spade. One of the current battles within the case concerns how to define the “affordable luxury handbag market”, and whether that market is defined by price point, materials, craftsmanship or quality, name-brand recognition, or even the country where the bag is produced. The case is ongoing, with a preliminary injunction hearing scheduled to begin on 9 September 2024, in the Southern District of New York.
The FTC’s increased scrutiny of mergers is also reflected in its recent suit to block Kroger’s USD24.6 billion acquisition of Albertsons. This acquisition is the largest proposed supermarket merger to date. A preliminary injunction hearing in the U.S. District Court for the District of Oregon is scheduled to begin on 26 August 2024, and to last until 13 September 2024. In addition to this federal preliminary injunction hearing, Kroger and Albertsons are facing state injunction proceedings in Colorado and Washington, that are scheduled to conclude by October 2024.
In July 2024, the FTC challenged the proposed USD4 billion vertical combination of Tempur Sealy International, Inc. and Mattress Firm Group Inc. The FTC alleged that Tempur Sealy is the largest US manufacturer of premium mattresses and that Mattress Firm is the largest retailer of premium mattresses. The FTC argues that the transaction would give Tempur Sealy the incentive and ability to substantially lessen competition by foreclosing its competitors’ access to Mattress Firm as a retail channel for competing products. A preliminary injunction hearing is scheduled for November 2024 in the Southern District of Texas.
Looking Ahead
Artificial Intelligence Investigations (AI)
The DOJ and the FTC have reportedly agreed to allocate investigations between the agencies concerning certain AI companies. According to news articles, the FTC will investigate OpenAI, which makes ChatGPT, and its major investor, Microsoft, for potential competition issues. The DOJ will look at Nvidia, the leading manufacturer of AI chips in the rapidly developing artificial intelligence space.
In January 2024, the FTC issued an inquiry based on Section 6(b) of the FTC Act requiring Alphabet, Inc., Microsoft Corp., OpenAI, Inc., and other companies to provide information regarding recent investments and partnerships involving generative AI companies and major cloud service providers.
Return of Robinson-Patman Act cases?
The FTC has indicated a heightened commitment to enforcing the Robinson-Patman Act. Although the FTC has yet to initiate a new suit under the Act, the FTC did file a petition in federal court in October 2023, seeking to compel Total Wine & More’s compliance with a subpoena related to an ongoing investigation pursuant to the statute.
The FTC is also reportedly considering filing a Robinson-Patman lawsuit against Southern Glazer’s Wine and Spirits, the largest US alcohol distributor. And in 2022, the FTC opened a similar investigation involving Coca-Cola and Pepsi for potential price discrimination. Both matters remain in the investigation phase.
2001 K Street
NW
Washington DC
20006
USA
+1 202 912 5000
+1 202 912 6000
leigh.oliver@cliffordchance.com www.cliffordchance.com/home.html